近日,fda官网披露了阿哌沙班(apixaban) 过山车式的审批过程.
阿哌沙班(apixaban)是由百时美施贵宝公司研发的一种可逆的凝血因子xa
rance),阿昔替尼(inlyta),恩扎卢胺(xtandi),抗凝药阿哌沙班(eliquis)
18家跨国药企2023财报概要汇总(附报告下载)|强生|单抗|艾伯维|总营收
值得一提的是,这也是fda批准的针对辉瑞/bms抗凝血剂eliquis(apixaban
Tips:Do Not Provide
Personal Loans: Go Easy On Your Finances
Finance, Finance, Finance, Foreign Exchange, Stocks, Currency Circle, Venture Capital, Bitcoin, ICO...